Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 685 Carcinoma, Non-Small-Cell Lung 328 Neoplasms 170 Breast Neoplasms 166 Lung Neoplasms 158 Urinary Bladder Neoplasms 157 Neoplasm Metastasis 140 Cholangiocarcinoma 113 Ovarian Neoplasms 106 Biliary Tract Neoplasms 95 Lymphoma, Large B-Cell, Diffuse 73 Nasopharyngeal Carcinoma 71 Lymphoma 66 Sarcoma 63 Recurrence 62 Gallbladder Neoplasms 61 Carcinoma, Transitional Cell 56 Triple Negative Breast Neoplasms 54 Hodgkin Disease 52 Colorectal Neoplasms 49 Lymphoma, Non-Hodgkin 48 Fallopian Tube Neoplasms 48 Adenocarcinoma 45 Bile Duct Neoplasms 40 Carcinoma, Ovarian Epithelial 31 Non-Muscle Invasive Bladder Neoplasms 30 Uterine Cervical Neoplasms 28 Carcinoma 28 Unspecified Adult Solid Tumor, Protocol Specific 27 Adenocarcinoma of Lung 27

Interventions

Fulvestrant 19 Letrozole 10 Anastrozole 8 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Injections 4 Goserelin 4 Docetaxel 4 trastuzumab deruxtecan 3 pyrotinib 3 exemestane 3 Vinorelbine 3 Aromatase Inhibitors 3 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 dalpiciclib 2 abemaciclib 2 Trastuzumab 2 Gonadotropin-Releasing Hormone 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Gemcitabine × Clear all

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡